These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30193587)

  • 21. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down syndrome individuals with Alzheimer's disease have a distinct neuroinflammatory phenotype compared to sporadic Alzheimer's disease.
    Wilcock DM; Hurban J; Helman AM; Sudduth TL; McCarty KL; Beckett TL; Ferrell JC; Murphy MP; Abner EL; Schmitt FA; Head E
    Neurobiol Aging; 2015 Sep; 36(9):2468-74. PubMed ID: 26103884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Anticholinergic Activity Affect Neuropathology? Implication of Neuroinflammation in Alzheimer's Disease.
    Yoshiyama Y; Kojima A; Itoh K; Isose S; Koide M; Hori K; Arai K
    Neurodegener Dis; 2015; 15(3):140-8. PubMed ID: 26138491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of Alzheimer's Disease-Related Pathology and Cell Counts in a Patient with Idiopathic Normal Pressure Hydrocephalus.
    Libard S; Laurell K; Cesarini KG; Alafuzoff I
    J Alzheimers Dis; 2018; 61(4):1451-1462. PubMed ID: 29376849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.
    Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D
    J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.
    Flores-Aguilar L; Iulita MF; Kovecses O; Torres MD; Levi SM; Zhang Y; Askenazi M; Wisniewski T; Busciglio J; Cuello AC
    Brain; 2020 Dec; 143(12):3653-3671. PubMed ID: 33206953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased hypothalamic microglial activation after viral-induced pneumococcal lung infection is associated with excess serum amyloid A production.
    Wang H; Blackall M; Sominsky L; Spencer SJ; Vlahos R; Churchill M; Bozinovski S
    J Neuroinflammation; 2018 Jul; 15(1):200. PubMed ID: 29980196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.
    Miron J; Picard C; Frappier J; Dea D; Théroux L; Poirier J
    J Alzheimers Dis; 2018; 63(4):1547-1556. PubMed ID: 29782315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial reduction of microglia does not affect tau pathology in aged mice.
    Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
    J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staining of HLA-DR, Iba1 and CD68 in human microglia reveals partially overlapping expression depending on cellular morphology and pathology.
    Hendrickx DAE; van Eden CG; Schuurman KG; Hamann J; Huitinga I
    J Neuroimmunol; 2017 Aug; 309():12-22. PubMed ID: 28601280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of cellular inflammatory responses in ageing white matter and relationship to Alzheimer's and small vessel disease pathologies.
    Waller R; Narramore R; Simpson JE; Heath PR; Verma N; Tinsley M; Barnes JR; Haris HT; Henderson FE; Matthews FE; Richardson CD; Brayne C; Ince PG; Kalaria RN; Wharton SB;
    Brain Pathol; 2021 May; 31(3):e12928. PubMed ID: 33336479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
    Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
    J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of the impact of systemic inflammation on neuroinflammation from a non-bacterial endotoxin animal model.
    Huang C; Irwin MG; Wong GTC; Chang RCC
    J Neuroinflammation; 2018 May; 15(1):147. PubMed ID: 29776428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.